Related by context. All words. (Click for frequent words.) 64 exclusivity 52 Early Termination 52 Patent Dispute 51 Licensing Deal 51 Licence Agreement 51 Patent Lawsuit 50 Trademark Dispute 50 License Agreement 50 Legal Dispute 49 Generic Version 49 Patent Infringement Case 49 Licensing Pact 49 Infringed 49 Patent Suit 49 Patent Ruling 48 Arthritis Drug 48 Milestone Payments 48 Preliminary Injunction Against 48 Licensing Agreements 48 Pending Litigation 48 Exclusivity Agreement 48 Infringement Case 48 Patent Infringement Suit 47 Generic Versions 47 Milestone Payment 47 Exclusive License 47 Infringes 47 Exclusivity Period 47 Schizophrenia Drug 47 Terminate Agreement 46 Antitrust Case 46 Questions Loom 46 Gout Drug 46 Migraine Drug 46 Distribution Agreements 46 Injunction Against 46 Patent Covering 46 Generic Protonix 46 Permanent Injunction 46 Royalty Rates 46 Fixed Dose Combination 46 Antidepressant Drug 46 Asset Swap 46 Orphan Designation 46 Inhaled Insulin 46 Patent Infringement Litigation 46 FDA Orphan Drug 46 Patents Covering 46 Infringement Suit 46 Enforceability 46 Exclusive Distribution 46 Conditional Approval 46 Significant Milestone 46 Authorized Generics 46 Testosterone Gel 46 Files IND 46 Infringing 46 Generic Version Of 45 Attorneys Fees 45 Inks License 45 License Agreements 45 Settle Patent Litigation 45 License Option Agreement 45 Discontinues 45 Weight Loss Drug 45 Expiration Dates 45 Confidentiality Agreement 45 License Pact 45 Regulatory Clearance 45 Licensing Agreement 45 Patent Portfolio 45 Supply Agreement 45 Regulatory Approvals 45 Injunction 45 Fast Track Status 45 DVD Copying 45 Antitrust Probe 45 Differentiation 45 Final Approval 45 Expanded Indication 45 FDA Panel Recommends 45 Waiting Period 45 Antitrust Suit 45 Receives Orphan Drug 44 Non Infringement 44 Patent Spat 44 Key Milestones 44 Resolves Dispute 44 Antitrust Lawsuit 44 Rheumatoid Arthritis Drug 44 PDUFA Date 44 mr holland brown 44 FDA Okays 44 Entered Into 44 Patent Infringement Suit Against 44 Inks Exclusive 44 ANDA Filing 44 Impartiality 44 Franchise Agreements 44 Patent Infringement Lawsuit 44 Sublicense 44 Signs Licensing 44 Overallotment 44 Trademark Lawsuit 44 Settle Litigation 44 Countersuit 44 Antitrust Settlement 44 Reacquires 44 relapsed refractory pediatric 44 Testosterone Patch 44 Osteoporosis Drug 44 Blood Pressure Drug 44 Waiver Agreement 44 Miraculins Announces 44 Registered Trademarks 44 Supply Agreements 44 Worldwide Licensing Agreement 44 Long Term Relationship 44 Action Lawsuit 44 Secures Patent 44 Acquires Exclusive 44 Infringe 44 Diet Pill 44 Humira Simponi 44 Noncompete 44 Monetizes 44 Receives FDA Approvable 44 Misonix Announces 44 Pricing Structure 44 Orphan Status 44 Resolve Dispute 44 Diamyd Medical Diamyd 44 Legal Tussle 44 Patent Infringement Claim 44 False Advertising 44 Derma Sciences Announces 44 Significantly Expand 44 Extends Offer 44 Secures Exclusive 43 Must Carry 43 Announce Settlement 43 NASDAQ Delisting 43 Vioxx Suits 43 Not Infringe 43 False Marking 43 Receives Complete Response 43 Sell Itself 43 Patent Validity 43 Patent Litigation 43 Renews Exclusive 43 Buyout Bid 43 Arbitration Agreements 43 Differentiates 43 Shareholder Lawsuits 43 Lung Cancer Drug 43 Trademark Suit 43 Patent Suit Against 43 Undervalues 43 Rehear 43 Settles Patent 43 Pending Acquisition 43 Generic Name 43 Tiered Pricing 43 Definitive Merger Agreement 43 XXX Domain 43 Gets Thumbs Down 43 Data Exclusivity 43 Generic Lipitor 43 Settle Patent 43 Clawback 43 Earns Milestone Payment 43 Drug Coated Stent 43 BioElectronics Corporation Announces 43 Ticket Resale 43 Marketing Authorisation 43 Share Buyback 43 Settles Charges 43 Patent Disputes 43 Patent Infringement 43 Sirius XM Merger 43 Patent Upheld 43 Acne Drug 43 Arbitration Clause 43 Renegotiation 43 Emisphere Technologies Announces 43 Intellectual Property Portfolio 43 Trademark Infringement 43 Taro Receives 43 XM Sirius Merger 43 Denies Bid 43 FTC Clears 43 Plaintiff Motion 43 Trademark Infringement Lawsuit 43 Voluntary Withdrawal 43 Termination Fee 43 Salix Pharma 43 Definitive Agreements 43 Authorized Generic 42 Patent Troll 42 Favorable Decision 42 PDL BioPharma Announces 42 Cannibalizing 42 Announce Licensing 42 Wins Approval 42 Patent Infringement Action 42 Highly Profitable 42 Confirms Patent 42 Eszopiclone 42 Satellite Radio Merger 42 VIVUS Announces 42 Prostate Cancer Vaccine 42 Psoriasis Drug 42 Milestone Payment From 42 Buyback Plan 42 Distribution Pact 42 Drug Candidate 42 Mandatory Arbitration 42 Drug Makers 42 FCC Approves 42 Patent Suits 42 iPhone Exclusivity 42 Copyright Infringement 42 Arbitration Clauses 42 Tortious Interference 42 Orphan Drug Status 42 Submits Supplemental 42 Forges Ahead 42 Positive Opinion 42 Multimillion Dollar 42 Arbitrate 42 Not Disclosed 42 Customisation 42 Trademarking 42 Compulsory License 42 Patent Term 42 Biogenerics 42 Spears Conservatorship 42 Non Transferable 42 Patents 42 Remain Listed 42 Device Makers 42 Unenforceable 42 Warrant Warrant 42 Shareholder Suits 42 Inequitable Conduct 42 Sponsorship Agreement 42 InvaGen 42 Leases 42 FDA Accepts 42 Gets Tentative 42 Refinances Debt 42 Receives Tentative FDA 42 Anemia Drug 42 Stock Soars 42 Patents Issued 42 Idenix Novartis 42 Present Preclinical Data 42 Differs From 42 Granted Orphan Drug 42 Forbearance 42 Cholesterol Lowering Drug 42 Knock Offs 42 Slashes Price 42 cefuroxime axetil 42 Medicure Announces 42 Exclusive Licensing 42 Deepwater Drilling Moratorium 42 Metabolic Disorder 42 Antitrust Ruling 42 Individuality 42 Favorable Ruling 42 Non Binding Letter 42 Distribution Agreement 42 Expedited Review 42 Alphapharm 42 Receives Unsolicited 42 Stock Buyback 42 Blood Thinner 42 Takeover Bid 42 Hatch Waxman 42 Glatiramer Acetate 42 Estoppel 42 Announces Tentative Approval 42 Teva Provides Update 42 Product Designation 42 Obtains Exclusive 42 Option Deed 42 Takeover Talks 42 Court Invalidates 42 Seems Unlikely 42 Settles Litigation 42 Signs Licensing Agreement 42 Marketability 42 BioSante Pharmaceuticals Announces 42 Transfer Agreement 42 Terminate Merger 42 Asset Sale 42 GRAS Status 41 Receives Fast Track 41 Controlling Stake 41 Infringement 41 Collaboration Agreement 41 Patent Reexamination 41 Suit Settled 41 Confidentiality 41 Counterfeit Drugs 41 Binding Agreement 41 Standstill 41 Compulsory Licensing 41 Preferable 41 Antitrust Clearance 41 GRALISE 41 Contract Dispute 41 nick holland brown fcis 41 Equity Stake 41 Settle Dispute Over 41 Partnering Agreements 41 Endorsement Deal 41 Financing Costs 41 Achieves Significant 41 Generic Biologics 41 Systemic Delivery 41 Expiration 41 Negative Feedback 41 Ringing Endorsement 41 Exec Says 41 Patenting 41 Wins Injunction 41 Court Throws Out 41 Obtains Exclusive Rights 41 Receives Notification 41 Receives Favorable 41 Hatch Waxman exclusivity 41 Restructures 41 Oxcarbazepine 41 Patent Invalid 41 Prompt Payment 41 Dividend Payments 41 Flamel Technologies Announces 41 Hostile Bid 41 Derivative Transactions 41 Successful Conclusion 41 Entails 41 Britney Spears Conservatorship 41 Markets Examine 41 Advanced Colorectal Cancer 41 Launches Generic Version 41 Confirms Validity 41 Terminate Merger Agreement 41 Leans Toward 41 Receives Patent 41 Marketing Authorization 41 Patent Licensing 41 Orphan designation 41 Patent License Agreement 41 Positions Itself 41 Summary Judgment Order 41 Acquisition Proposal 41 Expands Scope 41 Obviousness 41 Cross License Agreement 41 Narrows 4Q Loss 41 exclusivities 41 Piracy Lawsuits 41 Receives Milestone Payment 41 xxx Domain 41 Monthly Subscription 41 mg Extended Release 41 Cladribine 41 HSR Waiting Period 41 Deal Imminent 41 Lamivudine 41 Enters Into Partnership 41 Entry Into 41 Renews Multi 41 Diversifies 41 Nears Launch 41 Enters Into Long Term 41 Unsolicited Tender Offer 41 Urges Rejection 41 Agreement 41 GBP# Million 41 Faces Suit 41 Lawsuit Dismissal 41 Announces License Agreement 41 Injunctive Relief 41 Files Patent 41 ZTEST Announces 41 Settles Dispute 41 Mylan Receives Approval 41 Nasdaq Delisting 41 Nears Deal 41 Negotiated Settlement 41 Atorvastatin 41 Files Trademark 41 Dominant Position 41 Agreements 41 Similac Recall 41 Inducement Awards 41 Arbitrations 41 Derivative Lawsuit 41 Upload Speeds 41 pediatric exclusivity 41 Submits NDA 40 Signs Definitive 40 IPhone Apps 40 Copyright Infringement Lawsuit 40 Clears Path 40 Signs Endorsement 40 Report Analyzes 40 ANDA filer 40 Co Branded 40 Repositions 40 FDA Clears 40 Attract Buyers 40 Foreseeable Future 40 Ad Targeting 40 Copy Protection 40 Subsidiary Enters 40 Multi Billion Dollar 40 Commercialization Agreement 40 Shipment Forecast 40 Seeks Buyer 40 Privacy Concerns 40 Intercreditor 40 Counteroffer 40 Data Suggest 40 Files Patents 40 Investigational Agent 40 Fast Track designations 40 Sublease 40 Net Neutrality Debate 40 Commences Subsequent 40 Renews Long Term 40 Shares Soar 40 Longer Term 40 Exclusive License Agreement 40 Ruling Upheld 40 Loyal Customers 40 Patentable 40 Antitrust Complaint 40 Unsolicited Proposal From 40 Biotech Firm 40 Inks Deals 40 Patent Infringement Lawsuit Against 40 Pennsaid R 40 Indecency Fine 40 Amends Agreement 40 Swipe Fee 40 Settles Patent Suit 40 Tablet Device 40 Rejects Attempt 40 Exclusive Licensee 40 Teva Pharma 40 Restructure Debt 40 Restraining Order 40 Recession Resistant 40 Lucrative 40 Stays Strong 40 Rejects Plea 40 Enters Into Distribution 40 Binding Arbitration 40 Obtains Financing 40 Ruling Upholding 40 CHMP Opinion 40 Widely Used 40 Trade Pacts 40 Cross Licensing Agreement 40 Age Bias 40 Repricing 40 Acquire Remaining 40 Fast Track Designation 40 Wins Patent Infringement 40 Awaits Approval 40 Long Term Incentive 40 '# Patents 40 Has Entered 40 Retrans 40 Cuts Update1 40 Underwriters Exercise 40 Rescission 40 Targeted Ads 40 Court Quashes 40 Oral Calcitonin 40 Trademarked 40 Seeks Injunction 40 Stipulated 40 RoFR 40 Farmout 40 Expiry Date Exercise 40 Submits Application 40 Receives Approvals 40 Orphan Drug Designation 40 Merger Talks 40 Termination 40 Unissued 40 Announce Definitive Merger 40 Prescription Drug Reimportation 40 Final Stages 40 Antitrust Litig 40 Carried Interest 40 Landline Phone 40 Mutuality 40 ONGLYZA TM 40 Remains Committed 40 Receives CE Marking 40 Ciclesonide 40 Increase Stake 40 FDA Approves Generic 40 Kwang Dong 40 Extends Tender Offer 40 Profits Drop 40 rabeprazole sodium 40 Sells Remaining 40 Competitive Position 40 Issues Resolved 40 Initiates Clinical 40 Terminates Letter 40 Reselling 40 Majority Ownership 40 TOP Ships Announces 40 Profits Soar 40 Dominance 39 Completes Transaction 39 Applauds FCC 39 Financing Commitment 39 Exec Pay 39 Headwaters Incorporated Announces 39 Bayer Onyx 39 refusal ROFR 39 Buyout Offer 39 Announces Definitive Merger 39 Regains Full 39 Controlling Interest 39 Directors Deferred Compensation 39 Initiates Voluntary Recall 39 Arbitration Proceedings 39 Ban Upheld 39 Superiority 39 Announce Exclusive 39 Tamsulosin 39 Hurdles Loom 39 Receives Favorable Ruling 39 Norgine BV 39 Licenses Patents 39 PlayBook Tablet 39 Exponential Growth 39 Offers Affordable 39 Stem Cell Patents 39 Pravastatin 39 Bupropion HCl ER 39 Lease Termination 39 Gets Clearance 39 Approves Share Repurchase 39 Announce Licensing Agreement 39 Announce Early Termination 39 Previously Announced Private Placement 39 Net Neutrality Rules 39 Sidesteps 39 Domain Name Dispute 39 Acacia Subsidiary Acquires 39 Deferrals 39 Recusal 39 Summary Judgment Motions 39 Lawsuit Settlement 39 Ownership Rules 39 Advantageous 39 Strengthens Balance Sheet 39 File Sharers 39 Option Grants 39 Spins Off 39 Chiesi Farmaceutici SpA 39 Court Voids 39 Acacia Subsidiary Enters 39 Secures Long Term 39 Wins Injunction Against 39 Debt Repayment 39 Settle Patent Dispute 39 LSE PFZ 39 INTUNIV TM 39 Signs License Agreement 39 galantamine hydrobromide 39 Patent Lawsuit Against 39 Underlines 39 Lawsuit Thrown Out 39 ProQuin XR 39 Lease Renewal 39 Broadens Its 39 Appeals Upholds 39 Finalize Agreement 39 Quantity 39 SES ASTRA Signs 39 Merger Discussions 39 Toned Down 39 Denies Motion 39 Amlodipine Besylate 39 Decision Delayed 39 Settle Lawsuit Over 39 Exclusive Distributorship 39 Strattera atomoxetine 39 Pacts 39 Insulin Pen 39 Signs Binding 39 Inks Distribution 39 Acquisition Spree 39 Obtains License 39 Taxable Income 39 Fewer Side Effects 39 Representation Agreement 39 Overrules 39 Sovereign Immunity 39 P2P File Sharing 39 Rebrands 39 Valeant Pharma 39 Defendant Motion 39 Sale Update1 39 Wi Fi Enabled 39 Too Costly 39 Patent Broadly Covering 39 DMCA Takedown 39 Suit Vs 39 FDA Approvals 39 MBS AFTERNOON 39 Plea Bargaining 39 SOLODYN R 39 Waiver Request 39 Biologic Drugs 39 Spin Off 39 Selectivity 39 Guarantees 39 Complementarity 39 Appears Imminent 39 Slimmed Down 39 Remains Unclear 39 Expiring 39 Board Unanimously Rejects 39 Files Provisional 39 Transition Period 39 Cause Confusion 39 Paragraph IV Certification 39 Officially Launched 39 Enter Into Definitive 39 ICANN Approves 39 called Microstructure Chromatograph 39 Rehearing 39 Ceftin 39 Submits IND 39 Ineffective Assistance 39 Committment 39 Wins Summary Judgment 39 Trademark License Agreement 39 Deriv 39 Achieves Milestone 39 Ephedra Ban 39 Terminates Agreement 39 Court Dismisses Lawsuit 39 WebTech Wireless Announces 39 Enters Into Multi 39 PRAVACHOL R 39 Justices Weigh 39 Resolve Dispute Over 39 Regarding Minimum Bid 39 sublicensed 39 Mulls Selling 39 Share Repurchase 39 Initiates Enrollment 39 Sustained Release 39 Success Depends 39 Minimum Bid 39 Declaratory Judgment 39 Kreutzer Limmer patent 39 Order Granting 39 Golden Parachutes 39 Malpractice Suit 39 Abortion Ruling 39 Must Disclose 39 Completes Patient Enrollment 39 Passes Milestone 39 Unserved 39 Elron Announces 39 Argues Against 39 Misleading Advertising 39 Accepts Plea 39 Quinapril 39 Affords 39 Sweeping Changes 39 Makes Hostile 39 Teva ANDA 39 Formalizes 39 Damages Claim 39 Workers Reach Tentative 39 Assignment Agreement 39 Files Countersuit Against 39 Wiretap Evidence 39 Piracy Crackdown 39 collagenase clostridium histolyticum 39 Yellowstone Snowmobile 39 Deserved Win 39 Illegal Downloads 39 XIAPEX 39 Announces Licensing Agreement 39 Pediatric Exclusivity 39 Loses Appeal Against 39 Issued Patent 39 Acquire Majority 39 Settles Patent Litigation 39 Vicious Dogs 39 File Sharing Case 39 Genetically Engineered Salmon 39 Recuse 39 Financing Arrangement 39 Enters Into Exclusive 39 Receives Confirmation 39 Clothing Retailer 39 Uncorks 39 Share Issuance 39 Dismisses Claims 39 Clarified 39 Takeover Bids 39 Restructures Debt 39 Buyer Representation 39 Approvable 39 Affiliation 39 Suspension Lifted 39 Codeshare 39 '# '# 39 Viable Alternative 39 Product Differentiation 39 Exclusion 39 Extends Collaboration 39 Deal Collapses 39 Judge Tosses Out 39 Completes Previously Announced 39 Stockholder Approval 39 Coinsurance 39 Renegotiating 39 FDA Approval 38 Jointly Announce 38 Takes Backseat 38 Buyout Talks 38 Tamoxifen Citrate 38 Regulatory Approval 38 Takeover Offer 38 Settle Trademark 38 Whitestone REIT Announces 38 Carve Out 38 Fee Dispute 38 Receive Milestone Payment 38 Discount Vouchers 38 Joinder 38 Ethical Considerations 38 Certified Partner Status 38 Confidentiality Agreements 38 Number Porting 38 File Swapping 38 Implementation Deed 38 Merger Transaction 38 Next Step Toward 38 Rumors Swirl 38 Permanent Injunction Against 38 Proposed Merger 38 Mulls Sale 38 Profits Climb 38 Judge Dismisses Suit 38 Integra LifeSciences Announces 38 Waives 38 Tablet Formulation 38 Sagging Economy 38 Blood Thinning 38 Patent Filing 38 Ruling Expected 38 R imatinib mesylate 38 Standstill Agreement 38 Acacia Subsidiary 38 Snaps Up 38 Cefdinir 38 Knockoffs 38 Prevacid Prilosec 38 Brand Loyalty 38 Announces Termination 38 Synthetic Peptide 38 Hedging Contracts 38 Desirability 38 Settle Antitrust 38 Transferrable 38 Treating Chronic 38 Shareholder Approval 38 Acquire Assets 38 Delist 38 Inks Supply 38 Resubmits 38 Guber Aspirant 38 Suit Filed 38 Venlafaxine 38 Tax Loophole 38 Knee Jerk Reaction 38 Termination Agreement 38 Definitive Option Agreement 38 Wireline Broadband 38 Portability 38 Decision Upholding 38 Loramyc ™ 38 Appeal Ruling 38 Severance Package 38 Confirms Commitment 38 Conflicted Over 38 Conditions Precedent 38 Dismiss Lawsuit 38 Buyout Firms 38 Timeframe 38 Evaporates 38 Custody Hearing 38 Licensor 38 Various Types 38 Hiring Spree 38 Reacquisition 38 generic Norvasc 38 Ceases 38 Same Sex Marriage Licenses 38 Announces Favorable Ruling 38 Suit Tossed 38 Announces FDA Clearance 38 Suit Dismissed 38 Temporary Injunction 38 Dealmaking Profile 38 Transaction Fees 38 Reduces Debt 38 Term Restoration 38 Paternity Leave 38 Files Patent Application 38 Quickie Divorce 38 AstraZeneca Toprol 38 Settle Lawsuits 38 Strategic Rationale 38 Sales Slump 38 Grossly Inadequate 38 Disconnection 38 Nutra Pharma Announces 38 Openness 38 Patriot Act Provisions 38 Licence Agreements 38 Legitimacy 38 Initiates Phase II 38 reacquires 38 Scoops Up 38 Judge Nixes 38 Pre nup 38 Collaborators Publish 38 Waivers 38 Long Awaited 38 Prospers 38 STERIS Corporation Announces 38 Intractable Hiccups 38 Long Term Incentive Compensation 38 Tumor Targeting 38 Distinctiveness 38 Amends Terms 38 Vigorously Defend 38 Disclosure Requirement 38 Commutations 38 #.#Bln 38 Enters Into Joint Venture 38 Enters Into Definitive 38 Paragraph IV 38 Ruling 38 Reaffirm 38 Shareholder Opposes 38 Expand Collaboration 38 OLEPTRO ™ 38 BPZ Energy Announces 38 SpeBio joint venture 38 Generates Buzz 38 Preliminary Injunction 38 NexMed Receives 38 Inks Long Term 38 Fifth Consecutive 38 Signs Multiyear 38 Option Schemes 38 Markman Ruling 38 Subordination 38 Tenth Consecutive 38 Lowest Price 38 Trobalt 38 Stavzor TM 38 Salary Arbitration 38 Sews Up 38 Biosimilar 38 Extend Partnership 38 Gets Rid Of 38 Negotiates 38 Wears Thin 38 Wafer Supply 38 Swap Counterparty 38 Receives Tentative Approval 38 Wellbutrin XL R 38 Relaunches Website 38 Complete Merger 38 Unfairness 38 Completes Enrollment 38 Preemption 38 Explores Possible 38 Eagerly Awaited 38 Stake Sale 38 Disconnects 38 Unconscionable 38 Remainder Of 38 Bottomed Out 38 Fully Subscribed 38 Settles Patent Dispute 38 Contingent Commissions 38 Flip Flopping 38 Reexamine 38 Terbinafine 38 Work Stoppage 38 Bid Update1 38 #,#,# #,#,# -LAS VEGAS MGM Resorts 38 Orphan Medicinal Product 38 Approves Sale 38 Reinvents Itself 38 Nondisclosure 38 Breakup Fee 38 Lexapro escitalopram 38 Case Dismissed 38 Sign License Agreement 38 Million Pounds Sterling 38 DOR BioPharma Announces 38 Dispensation 38 Passport Requirement 38 Upholds Ruling 38 Resale Value 38 Court Dismisses 38 #.#B Vioxx 38 Enters Into Licensing Agreement 38 Divesture 38 Buyout Deal 38 Practicality 38 Cash Infusion 38 Concludes Acquisition 38 Dispute Continues 38 Due Diligence Period 38 Disloyalty 38 Request Denied 38 Generic Drugs 38 Clearford Announces 38 Receives Notice 38 Balance Sheet Restructuring 38 Arbitration Proceeding 38 Gets Approval 38 Posts Wider Loss 38 Typosquatting 38 Maximize Shareholder Value 38 Lay Offs 38 Without Sacrificing 38 Cell Phone Directory 38 3Q Loss Widens 38 Significant Portion 38 Cuts Costs 38 Enters Exclusive 38 divalproex ER 38 microRNA Therapeutics 38 Benazepril 38 Extend Contract 38 Unlimited Downloads 38 Anonymity 38 Rumors Abound 38 Credit Card Consolidation 38 Withdrawal 38 b#x# http:/#.#.#.#/fls.geo/PH #x# #.hyahrtzeit 38 Invalidity 38 StockSource.us Reports USOG 38 Precedent Setting 38 Underpin 38 Valganciclovir 38 RAZADYNE 38 Becomes Effective 38 Instant Gratification 38 Appeal Dismissed 38 Nasacort 37 Approval Process 37 Asthma Inhalers 37 Raise Stake 37 Declaratory Relief 37 Transferable 37 Credit Card Payments 37 Avian Flu Vaccine 37 Its Previously Announced 37 Execute Definitive 37 IPv4 Addresses 37 Exclusive Licensing Agreement 37 Edges Closer 37 Rejects Bid 37 Sponsorship Deal 37 Makes Unsolicited Bid 37 Gay Marriage Advocates 37 Discretion 37 nhs remuneration 37 Deals Blow 37 Like Hotcakes 37 Match Guarantee